#172 Drugs for male- and female-pattern baldness: Just a hair bit more effective than doing nothing?
CLINICAL QUESTION
What is the effect of approved medications for androgenic alopecia in men and women?
BOTTOM LINE
For men using finasteride or minoxidil, one in 4-8 more than placebo will notice at least slight improvement in hair count over 6-12 months, with no clear evidence one is better. For every 84 men taking finasteride for hair loss, one extra will experience erectile dysfunction. For women, only minoxidil improves hair count, with one in eight reporting a moderate improvement over placebo.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
- Men:
- Finasteride: Systematic review1 (12 randomized controlled trials (RCTs), 3,927 men) of finasteride 1-5 mg/day versus placebo found:
- At least slight improvement in hair count at 3-12 months, 43% versus 26%, Number Needed to Treat (NNT)=6.
- At 24-60 months, NNT=4.
- Increase in hair counts at balding spots.
- 9% at 3-12 months, 24% at 48 months.
- Increase in erectile dysfunction, Number Needed to Harm (NNH)=84.
- No difference in other sexual adverse effects.
- Limitations: Publication bias, selective reporting (under-reporting sexual adverse effects),3 high loss to follow-up (up to 30%), clinically important differences undefined.
- Recent, low quality systematic review found similar.2
- At least slight improvement in hair count at 3-12 months, 43% versus 26%, Number Needed to Treat (NNT)=6.
- Minoxidil: Systematic review4 (11 RCTs, 1,666 men), minoxidil 2% solution BID versus placebo over 6-12 months found:
- At least slight improvement in hair count, 62% versus 40%, NNT=5.
- 16% increase in hair counts.
- Higher (versus lower) concentrations inconsistently show slight (2-4%) increase hair count.5,6
- Adverse effects: Application-site reactions most common (2-6%), more with higher concentrations.5-7
- Finasteride: Systematic review1 (12 randomized controlled trials (RCTs), 3,927 men) of finasteride 1-5 mg/day versus placebo found:
- Only trial comparing finasteride to minoxidil: Poor quality and unreliable.8
- Women: Systematic review.9
- Finasteride 1 mg (three RCTs, 287 women): No difference in any outcome.
- Minoxidil 1-5% versus placebo:
- Patient-rated moderate improvement or better (26% versus 14%, NNT=8)
- Increase in hair count, +13 hairs/cm2, at 6-12 months.
- Prevalence of androgenic alopecia increases with age, with approximately ½ of men and ⅓ of women balding after age 70.10
- Numerous other interventions (like nutritional supplements or Handi-Dome Comb) have low quality evidence with inconsistent results.9,11
- Only minoxidil for women or men, and finasteride for men, are supported in guidelines.12,13
Latest Tools for Practice
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)
What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
